Skip to main content
. 2022 Jul 22;101(29):e29668. doi: 10.1097/MD.0000000000029668

Table 4.

Survival analysis of the subgroups of IDH/TERT/1p/19q in lower-grade gliomas (26 cases).

Group Case Median survival time (mo) P
IDH mutation/TERT mutation/1p/19q deletion 13 32 0.007
IDH mutation/TERT wild-type/1p/19q nondeletion 13 22
IDH mutation/1p/19q deletion 15 31 0.249
IDH mutation/1p/19q nondeletion 11 27